The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Polyethyleneimine-modified iron oxide nanoparticles for brain tumor drug delivery using magnetic targeting and intra-carotid administration
Open accessAbstract
This study aimed to examine the applicability of polyethyleneimine (PEI)-modified magnetic nanoparticles (GPEI) as a potential vascular drug/gene carrier to brain tumors. In vitro, GPEI exhibited high cell association and low cell toxicity – properties which are highly desirable for intracellular drug/gene delivery. In addition, a high saturation magnetization of 93 emu/g Fe was expected to facilitate magnetic targeting of GPEI to brain tumor lesions. However, following intravenous administration, GPEI could not be magnetically accumulated in tumors of rats harboring orthotopic 9L-gliosarcomas due to its poor pharmacokinetic properties, reflected by a negligibly low plasma AUC of 12 ± 3 μg Fe/ml*min. To improve “passive” GPEI presentation to brain tumor vasculature for subsequent “active” magnetic capture, we examined the intra-carotid route as an alternative for nanoparticle administration. Intra-carotid administration in conjunction with magnetic targeting resulted in 30-fold (p = 0.002) increase in tumor entrapment of GPEI compared to that seen with intravenous administration. In addition, magnetic accumulation of cationic GPEI (ζ-potential = + 37.2 mV) in tumor lesions was 5.2-fold higher (p = 0.004) than that achieved with slightly anionic G100 (ζ-potential = −12 mV) following intra-carotid administration, while no significant accumulation difference was detected between the two types of nanoparticles in the contra-lateral brain (p = 0.187). These promising results warrant further investigation of GPEI as a potential cell-permeable, magnetically-responsive platform for brain tumor delivery of drugs and genes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mosmann, T. (1983) · Journal of Immunological Methods · doi:10.1016/0022-1759(83)90303-4 · Cited by 56,104
Color test for detection of free terminal amino groups in the solid-phase synthesis of peptides
Kaiser, E., Colescott, R. L., Bossinger, C. D., & Cook, P. I. (1970) · Analytical Biochemistry · doi:10.1016/0003-2697(70)90146-6 · Cited by 3,516
Wang, Y.-X. J., Hussain, S. M., & Krestin, G. P. (2001) · European Radiology · doi:10.1007/s003300100908 · Cited by 1,381
Chertok, B., Moffat, B. A., David, A. E., Yu, F., Bergemann, C., Ross, B. D., & Yang, V. C. (2008) · Biomaterials · doi:10.1016/j.biomaterials.2007.08.050 · Cited by 900
Self-citationMagnetic nanoparticles for drug delivery
Dobson, J. (2006) · Drug Development Research · doi:10.1002/ddr.20067 · Cited by 886
Locoregional cancer treatment with magnetic drug targeting.
Alexiou, C., Arnold, W. J., Klein, R. J., Parak, F., Hulin, P., Bergemann, C., Erhardt, W. D., Wagenpfeil, S., & Lübbe, A. S. (2000) · PubMed · Cited by 863
Lübbe, A. S., Bergemann, C., Riess, H. B., Schriever, F., Reichardt, P., Possinger, K., Matthias, M., Dörken, B., Herrmann, F., Gürtler, R., et al. (1996) · PubMed · Cited by 652
Friedman, M. (2004) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf030490p · Cited by 647
The blood-brain and blood-tumor barriers: A review of strategies for increasing drug delivery
Groothuis, D. R. (2000) · Neuro-Oncology · doi:10.1093/neuonc/2.1.45 · Cited by 456
Cationic liposomes target angiogenic endothelial cells in tumors and chronic inflammation in mice.
Thurston, G., McLean, J. W., Rizen, M., Baluk, P., Haskell, A., Murphy, T. J., Hanahan, D., & McDonald, D. M. (1998) · Journal of Clinical Investigation · doi:10.1172/jci965 · Cited by 423
Doolittle, N. D., Miner, M. E., Hall, W. A., Siegal, T., Hanson, E. J., Osztie, E., McAllister, L. D., Bubalo, J. S., Kraemer, D. F., Fortin, D., et al. (2000) · Cancer · doi:10.1002/(sici)1097-0142(20000201)88:3<637::aid-cncr22>3.0.co;2-y · Cited by 399
Preclinical experiences with magnetic drug targeting: tolerance and efficacy.
Lübbe, A. S., Bergemann, C., Huhnt, W., Fricke, T., Riess, H. B., Brock, J., & Huhn, D. (1996) · PubMed · Cited by 397
Campbell, R. B., Fukumura, D., Brown, E. B., Mazzola, L. M., Izumi, Y., Jain, R. K., Torchilin, V. P., & Munn, L. L. (2002) · PubMed · Cited by 372
Colloidal carriers and blood–brain barrier (BBB) translocation: A way to deliver drugs to the brain?
Garcia-Garcia, E., Andrieux, K., Gil, S., & Couvreur, P. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.03.031 · Cited by 314
A polymer library approach to suicide gene therapy for cancer
Anderson, D. G., Peng, W., Akinc, A., Hossain, N., Kohn, A., Padera, R., Langer, R., & Sawicki, J. A. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407218101 · Cited by 258
A critical evaluation of the principles governing the advantages of intra-arterial infusions
Eckman, W. W., Patlak, C. S., & Fenstermacher, J. D. (1974) · Journal of Pharmacokinetics and Biopharmaceutics · doi:10.1007/bf01059765 · Cited by 183
The blood-brain and blood-tumor barriers: A review of strategies for increasing drug delivery
Groothuis, D. R. (2000) · Neuro-Oncology · doi:10.1215/s1522851799000307 · Cited by 168
Vascular Microenvironment in Gliomas
Vajkoczy, P., & Menger, M. D. (2000) · Journal of Neuro-Oncology · doi:10.1023/a:1006474832189 · Cited by 167
Doxorubicin-loaded nanospheres bypass tumor cell multidrug resistance
Cuvier, C., Roblot-Treupel, L., Millot, J. M., Lizard, G., Chevillard, S., Manfait, M., Couvreur, P., & Poupon, M. (1992) · Biochemical Pharmacology · doi:10.1016/0006-2952(92)90443-m · Cited by 156
McBain, S. C., Yiu, H. H. P., Haj, A. J. E., & Dobson, J. (2007) · Journal of Materials Chemistry · doi:10.1039/b617402g · Cited by 143
Cognitive Functioning and Quality of Life in Malignant Glioma Patients: A Review of the Literature
Weitzner, M. A., & Meyers, C. A. (1997) · Psycho-Oncology · doi:10.1002/(sici)1099-1611(199709)6:3<169::aid-pon269>3.0.co;2-# · Cited by 134
Uptake and Metabolism of a Dual Fluorochrome Tat-nanoparticle in HeLa Cells
Koch, A., Reynolds, F., Kircher, M. F., Merkle, H. P., Weissleder, R., & Josephson, L. (2003) · Bioconjugate Chemistry · doi:10.1021/bc034123v · Cited by 129
Colloidal magnetic resonance contrast agents: effect of particle surface on biodistribution
Papisov, M. I., Bogdanov, A. A., Jr., Schaffer, B., Nossiff, N. D., Shen, T. T., Weissleder, R., & Brady, T. J. (1993) · Journal of Magnetism and Magnetic Materials · doi:10.1016/0304-8853(93)91115-n · Cited by 120
Chertok, B., Cole, A. J., David, A. E., & Yang, V. C.-M. (2009) · Molecular Pharmaceutics · doi:10.1021/mp900161h · Cited by 103
Self-citationBrigger, I., Morizet, J., Laudani, L., Aubert, G., Appel, M., Velasco, V., Terrier-Lacombe, M.-J., Desmaële, D., d’Angelo, J., Couvreur, P., et al. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.07.019 · Cited by 101
Holzapfel, V., Lorenz, M. R., Weiss, C. K., Schrezenmeier, H., Landfester, K., & Mailänder, V. (2006) · Journal of Physics Condensed Matter · doi:10.1088/0953-8984/18/38/s04 · Cited by 97
Chemotherapy of brain tumors: physiological and pharmacokinetic considerations.
Blasberg, R. G., & Groothuis, D. R. (1986) · PubMed · Cited by 95
Targeted drug delivery for brain cancer treatment
Gutman, R. L., Peacock, G., & Lu, D. R. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00229-1 · Cited by 87
Ross, B. D., Zhao, Y.-J., Neal, E. R., Stegman, L. D., Ercolani, M. C., Ben‐Yoseph, O., & Chenevert, T. L. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.12.7012 · Cited by 84
Malignant Gliomas in 2005: Where to GO From Here?
Fisher, P. G., & Buffler, P. A. (2005) · JAMA · doi:10.1001/jama.293.5.615 · Cited by 76
Enhanced Brain Tumor Selectivity of Cationic Magnetic Polysaccharide Microspheres
Pulfer, S. K., & Gallo, J. M. (1998) · Journal of drug targeting · doi:10.3109/10611869808997896 · Cited by 70
Potential of gene therapy for brain tumors
Lam, P. Y. P. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.7.777 · Cited by 68
Joshi, S., Emala, C. W., & Pile‐Spellman, J. (2007) · Journal of Neurosurgical Anesthesiology · doi:10.1097/ana.0b013e318033da41 · Cited by 27
Cited by
Ghosh Chaudhuri, R., & Paria, S. (2012) · Chemical Reviews · doi:10.1021/cr100449n · Cited by 3,614
Science and technology roadmap for graphene, related two-dimensional crystals, and hybrid systems
Ferrari, A. C., Bonaccorso, F., Fal'ko, V., Novoselov, K. S., Roche, S., Bøggild, P., Borini, S., Koppens, F. H. L., Palermo, V., Pugno, N., et al. (2015) · Nanoscale · doi:10.1039/c4nr01600a · Cited by 3,027
Kango, S., Kalia, S., Celli, A., Njuguna, J., Habibi, Y., & Kumar, R. (2013) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2013.02.003 · Cited by 2,157
Reddy, L. H., Arias, J. L., Nicolas, J., & Couvreur, P. (2012) · Chemical Reviews · doi:10.1021/cr300068p · Cited by 2,010
Nanoparticles: a boon to drug delivery, therapeutics, diagnostics and imaging
Parveen, S., Misra, R., & Sahoo, S. K. (2012) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2011.05.016 · Cited by 1,436
Metadata
- Authors
- Chertok, B., David, A. E., & Yang, V. C.
- Venue
- Biomaterials
- Publisher
- Elsevier BV
- Published
- 2010-08
- Volume
- 31
- Issue
- 24
- Pages
- 6317-6324
- ISSN
- 0142-9612 (ISSN-L)
- OpenAlex
- W2087959569
- Cited by
- 369
- References
- 33
- FWCI
- 10.86
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.